BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20186621)

  • 21. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer.
    Mita K; Ito H; Fukumoto M; Murabayashi R; Koizumi K; Hayashi T; Kikuchi H
    Am J Surg; 2012 Jan; 203(1):107-11. PubMed ID: 21474116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years.
    Lello E; Furnes B; Edna TH
    Acta Oncol; 2007; 46(3):308-15. PubMed ID: 17450465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced gastric cancer in the middle one-third of the stomach: Should surgeons perform total gastrectomy?
    Jang YJ; Park MS; Kim JH; Park SS; Park SH; Kim SJ; Kim CS; Mok YJ
    J Surg Oncol; 2010 May; 101(6):451-6. PubMed ID: 19924722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palliative gastrectomy in patients with stage IV gastric cancer--our recent experience.
    Lupaşcu C; Andronic D; Ursulescu C; Vasiluţă C; Raileanu G; Georgescu St; Niculescu D; Crumpei F; Târcoveanu E
    Chirurgia (Bucur); 2010; 105(4):473-6. PubMed ID: 20941968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of D2 gastrectomy for gastric adenocarcinoma: 10-year experience in Thai patients.
    Euanorasetr C; Lertsithichai P
    J Med Assoc Thai; 2007 Feb; 90(2):291-300. PubMed ID: 17375634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The surgical treatment of gastric carcinoma. Evolution in surgical technique and staging in a series of 194 patients].
    Tersigni R; Alessandroni L; Baiano G; Mencacci R; Miceli M; Sadighi A; Sorgi G; Tremiterra S
    Minerva Chir; 2004 Oct; 59(5):479-87. PubMed ID: 15494675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
    Bösing NM; Heise JW; Röher HD
    Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.
    Huscher CG; Mingoli A; Sgarzini G; Sansonetti A; Lirici MM; Napolitano C; Piro F
    Am J Surg; 2004 Dec; 188(6):728-35. PubMed ID: 15619491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
    Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decisions for extent of gastric surgery in gastric cancer patients: younger patients require more attention than the elderly.
    Lee JH; Ryu KW; Lee JS; Lee JR; Kim CG; Choi IJ; Park SR; Kook MC; Kim YW; Bae JM
    J Surg Oncol; 2007 May; 95(6):485-90. PubMed ID: 17195172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer.
    Shen JG; Cheong JH; Hyung WJ; Kim J; Choi SH; Noh SH
    J Surg Oncol; 2005 Aug; 91(2):126-30. PubMed ID: 16028285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choice of the surgical treatment in early gastric cancer.
    Custureri F; D'Orazi V; Peparini N; Gabatel R; Urciuoli P; Patrizi G; Redler A; Di Matteo G
    Hepatogastroenterology; 2004; 51(58):1210-4. PubMed ID: 15239281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Result of 11,946 gastric cancer treatment with immunochemosurgery.
    Kim JP; Lee JH; Yu HJ; Yang HK
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():206-14. PubMed ID: 10895156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stage-adapted radical principles in gastric carcinoma].
    Verreet PR
    Praxis (Bern 1994); 1998 Mar; 87(13):447-50. PubMed ID: 9584570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.